ORLANDO -- A non-hormonal treatment for menopausal moderate-to-severe vasomotor symptoms that just nabbed FDA approval was safe and well-tolerated up to 1 year of treatment, according to a pooled-data ...

With a median follow-up of 7.5 years, a new analysis found that an investigational gene therapy showed ___ overall survival ...

While most over-the-counter pain relievers are not recommended for use during pregnancy, acetaminophen is backed by decades' ...

ATLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated ...

Tony Lyons, who runs MAHA Action and other MAHA-related groups supporting Kennedy and his agenda, leads Kennedy's longtime ...

Home automatic external defibrillators (AEDs) modestly improve survival in shockable cardiac arrests but are not currently ...

Even in the case of resectable disease status, the prognosis for pancreatic cancer remains poor. Evidence from multiple ...

The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...

Reality television star Kim Kardashian disclosed on her show "The Kardashians" that she was diagnosed with a brain aneurysm, ...

Game two of the World Series, played Saturday night in Toronto, will include a performance by the Jonas Brothers in tribute ...

NIH Director Jay Bhattacharya, MD, PhD, sent an email to staff late last Friday announcing that Kyle Walsh, PhD, a ...